Vicplas International, the manufacturer of PVC pipes, pipe fittings and electrical conduits for the medical and building industries, has swung back to the black, thanks to better sales.
In the FY15 ended July, Vicplas registered earnings of $5.8 million from a loss of $4.1 million a year ago. Full-year revenue rose 17.1% to $74.1 million from a year ago.
Sales from the medical devices segment was $23.3 million in FY15, an increase of 9% from FY14 due to the increase in orders.
Sales from the pipes and pipe-fitting segment improved 22% to $50.8 million due to an increase in product offerings and expansion of customer base as its services and products were marketed to the local construction and civil engineering sectors.
Other income also increased by 61.7% as there was additional mould-making work completed in FY2015 compared to FY2014.
In its outlook for FY16, Vicplas is cautiously optimistic of an improvement in its results compared to FY15, based on expectations of better performance from the medical devices segment and the regional and product expansion of its pipes and pipe fittings segment.
Vicplas closed 4.6% higher at 7 cents.
Click Here To Register For Free Trial Services OR Give A Missed Call : +6531581402 Follow Us On Twitter : www.twitter.com/epicresearchsg Like Us On Facebook : www.facebook.com/EpicResearchSingapore Need Any Assistance Feel Free To Mail Us at : info@epicresearch.sg
In the FY15 ended July, Vicplas registered earnings of $5.8 million from a loss of $4.1 million a year ago. Full-year revenue rose 17.1% to $74.1 million from a year ago.
Sales from the medical devices segment was $23.3 million in FY15, an increase of 9% from FY14 due to the increase in orders.
Sales from the pipes and pipe-fitting segment improved 22% to $50.8 million due to an increase in product offerings and expansion of customer base as its services and products were marketed to the local construction and civil engineering sectors.
Other income also increased by 61.7% as there was additional mould-making work completed in FY2015 compared to FY2014.
In its outlook for FY16, Vicplas is cautiously optimistic of an improvement in its results compared to FY15, based on expectations of better performance from the medical devices segment and the regional and product expansion of its pipes and pipe fittings segment.
Vicplas closed 4.6% higher at 7 cents.
Click Here To Register For Free Trial Services OR Give A Missed Call : +6531581402 Follow Us On Twitter : www.twitter.com/epicresearchsg Like Us On Facebook : www.facebook.com/EpicResearchSingapore Need Any Assistance Feel Free To Mail Us at : info@epicresearch.sg
0 comments:
Post a Comment